Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)
Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –
Integra LifeSciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Integra LifeSciences's operating income for the twelve months ending Sep 30, 2026 was $72.70M. For fiscal 2025 it was -$493.37M, down 1836.5% from the year before. The highest annual figure on record is $238.92M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$493.37M | -1836.5% |
| FY2024 | Dec 31, 2024 | $28.41M | -74.5% |
| FY2023 | Dec 31, 2023 | $111.53M | -53.3% |
| FY2022 | Dec 31, 2022 | $238.92M | +21.1% |
| FY2021 | Dec 31, 2021 | $197.23M | +30.3% |
| FY2020 | Dec 31, 2020 | $151.37M | +61.4% |
| FY2019 | Dec 31, 2019 | $93.76M | -15.5% |
| FY2018 | Dec 31, 2018 | $111.00M | +147.7% |
| FY2017 | Dec 31, 2017 | $44.80M | -61.2% |
| FY2016 | Dec 31, 2016 | $115.34M | +44.9% |
| FY2015 | Dec 31, 2015 | $79.59M | +17.3% |
| FY2014 | Dec 31, 2014 | $67.86M | +91.8% |
| FY2013 | Dec 31, 2013 | $35.37M | -52.1% |
| FY2012 | Dec 31, 2012 | $73.78M | +34.4% |
| FY2011 | Dec 31, 2011 | $54.91M | -44.4% |
| FY2010 | Dec 31, 2010 | $98.69M | +0.9% |
| FY2009 | Dec 31, 2009 | $97.82M | +106.3% |
| FY2008 | Dec 31, 2008 | $47.41M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.90M | +60.7% |
| Q2 FY2026 | Jun 30, 2026 | $19.29M | – |
| Q1 FY2026 | Mar 31, 2026 | $11.47M | – |
| Q4 FY2025 | Dec 31, 2025 | $23.04M | -35.3% |
| Q3 FY2025 | Sep 30, 2025 | $11.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$512.67M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.50M | -490.9% |
| Q4 FY2024 | Dec 31, 2024 | $35.63M | -1.2% |
| Q3 FY2024 | Sep 30, 2024 | -$8.15M | -130.6% |
| Q2 FY2024 | Jun 30, 2024 | -$3.03M | -124.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.96M | -89.1% |
| Q4 FY2023 | Dec 31, 2023 | $36.05M | -46.9% |
| Q3 FY2023 | Sep 30, 2023 | $26.59M | -59.1% |
| Q2 FY2023 | Jun 30, 2023 | $12.50M | -79.1% |
| Q1 FY2023 | Mar 31, 2023 | $36.38M | -21.2% |
| Q4 FY2022 | Dec 31, 2022 | $67.84M | +16.5% |
| Q3 FY2022 | Sep 30, 2022 | $65.05M | +15.3% |
| Q2 FY2022 | Jun 30, 2022 | $59.87M | +15.5% |
| Q1 FY2022 | Mar 31, 2022 | $46.16M | +50.3% |
| Q4 FY2021 | Dec 31, 2021 | $58.22M | +10.6% |
| Q3 FY2021 | Sep 30, 2021 | $56.44M | -1.9% |
| Q2 FY2021 | Jun 30, 2021 | $51.85M | +268.3% |
| Q1 FY2021 | Mar 31, 2021 | $30.71M | +13.3% |
| Q4 FY2020 | Dec 31, 2020 | $52.65M | +45.9% |
| Q3 FY2020 | Sep 30, 2020 | $57.54M | – |
| Q2 FY2020 | Jun 30, 2020 | $14.08M | -69.4% |
| Q1 FY2020 | Mar 31, 2020 | $27.10M | -16.1% |
| Q4 FY2019 | Dec 31, 2019 | $36.08M | +5.8% |
| Q3 FY2019 | Sep 30, 2019 | -$20.59M | -186.9% |
| Q2 FY2019 | Jun 30, 2019 | $45.96M | +66.3% |
| Q1 FY2019 | Mar 31, 2019 | $32.31M | +26.3% |
| Q4 FY2018 | Dec 31, 2018 | $34.11M | +372.5% |
| Q3 FY2018 | Sep 30, 2018 | $23.68M | +122.5% |
| Q2 FY2018 | Jun 30, 2018 | $27.63M | +62.7% |
| Q1 FY2018 | Mar 31, 2018 | $25.58M | +156.8% |
| Q4 FY2017 | Dec 31, 2017 | $7.22M | -82.3% |
| Q3 FY2017 | Sep 30, 2017 | $10.64M | – |
| Q2 FY2017 | Jun 30, 2017 | $16.99M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.96M | – |
| Q4 FY2016 | Dec 31, 2016 | $40.77M | – |
See a number that looks wrong?